Latest Breaking News On - அளவுகோல்கள் க்கு நிறுவனம் - Page 1 : comparemela.com

Global $962 Million Oncolytic Virus Therapies Market to 2030

Global $962 Million Oncolytic Virus Therapies Market to 2030
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United statesLaura woodOncolytics biotech incViralytics ltdNational cancer instituteOffice hours callCriteria for companyResearch methodologyShanghai sunway biotech co ltdResearch fundingCompany profilesMerck co incE st office hours callSorrento therapeutics incTakara bio incAmgen inc

Global $962 Million Oncolytic Virus Therapies Market to 2030

Worldwide Solid Tumor Testing Industry to 2030 - Technological Advancements in the Field of Cancer Genomics Present Opportunities

Share this article Share this article ResearchAndMarkets.com s offering. This report highlights that the market is projected to reach $40.6 billion by 2030. The study also highlights that the market is set to witness a CAGR of 6.09% during the period 2020-2030. The market is driven by the need for the development of an advanced solution based on various technologies such as next-generation sequencing, in-situ hybridization, and polymerase chain reaction for cancer research in various applications such as diagnosis, prognosis, and treatment. The market is favored by the development of high-throughput, rapid, sensitive, and multi-parametric solutions for prognosis, diagnostics, and treatment. The gradual increase in the prevalence of cancer globally has furthered the solid tumor testing market.

United statesLaura woodRole of invitae corporation incRole of invivoscribe incRole of bio rad laboratories incInvitae corporationRole of quest diagnosticsRoche ltdInvivoscribe incCompany overviewOffice hours callLaboratory corporation of america holdingsResearch methodologyAsuragen incNeogenomics laboratories incRole of guardant health

Worldwide Precision Psychiatry Industry to 2026 - by Product Type, Biomarker Type, Sample, Technology, Application, End-user and Region

Global Increase in Mental Health Burden Market Challenges Lack of Awareness for Precision Psychiatry Diagnostics Market Opportunities Massive Scope for Adoption of NGS-Based Genetic Tests in Emerging Markets Key Companies Profiled Illumina, Inc., F. Hoffmann-La Roche Ltd., Bio-Rad Laboratories, Inc., QIAGEN N.V., Quest Diagnostics Incorporated, ARUP Laboratories, Invitae Corporation, OPKO Health, Inc., Laboratory Corporation of America Holdings, Centogene N.V., Thermo Fisher Scientific Inc., Myriad Genetics, Inc., Konica Minolta, Inc., Fulgent Genetics, PreventionGenetics Key Questions Answered in this Report: How is precision psychiatry revolutionizing the field of mental health diagnostics? What are the major market drivers, challenges, and opportunities in the global precision psychiatry market?

United statesUnited kingdomSouth koreaLaura woodPrecision diagnostics for drug developmentRole of invitae corporation incQuest diagnostics incorporatedRole of bio rad laboratories incHealth incInvitae corporationGlobal increase in mental health burdenKonica minolta incRoche ltdRole of myriad genetics incCompany overviewOffice hours call

Spatial Genomics and Transcriptomics Market, 2030

Spatial Genomics and Transcriptomics Market, 2030 News provided by Share this article Share this article ResearchAndMarkets.com s offering. Global Spatial Genomics and Transcriptomics Market to Reach $2,173.0 Million by 2030, progressing at a CAGR of 23.20%. The market is driven by certain factors, which include the increasing prevalence of various types of genetic disorders, such as cancer, neurological disorder, and rare diseases, inciting the development of high-resolution multiplex assays and instruments, technological advancements in sequencing technologies, and significant research funding in the field of spatial-based technology for executing R&D exercises. The market is favored by the development of spatial profiling-based solutions for visualization and analysis of tissue microenvironment, tumor biology, and tissue biomarker. The gradual increase in the prevalence of neurological disorders and rare diseases globally has furthered the spatial genomics and transcripto

United statesMiltenyi biotecLaura woodContract research organizationBiotechnological companiesNanostring technologies incIonpath incGeneration tissue exploration technologyGenomics incSpatial omics technologyResearch applicationBio techne corporationRarecyte incCompany overviewOffice hours callCriteria for company